Sign In
Last checked at 
20 Aug 2015 07:00
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Notice of Results
Investor Results Presentations
Cambridge Cognition Holdings plc (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, will be reporting its interim results for the six months ended 30 June 2015 on Thursday 10 September 2015.
Analyst presentation
Steven Powell, Chief Operating Officer and Nick Walters, Chief Financial Officer will be hosting an analyst briefing on the day of results, Thursday 10 September 2015, at 9.30am at Walbrook PR, 4 Lombard Street, London, EC3V 9HD.
Investor results presentation
A briefing for all investors will take place on Monday 14 September 2015 at Rocket, 6 Adams Court, Old Broad Street, London, EC4N 1DX from 4.30pm for a 4.45pm start, and will be followed by drinks and canapés.
If you would like to register to attend either presentation, or require further information, please contact Lianne Cawthorne on +44(0)20 7933 8788 or email camcog@walbrookpr.com.
Enquiries:
Cambridge Cognition Holdings plc | www.cambridgecognition.com | |
Steven Powell, Chief Operating Officer | Tel: 01223 810 700 | |
Nick Walters, Chief Financial Officer |
| |
|
| |
finnCap Ltd (Nomad and Broker) | Tel: 020 7220 0500 | |
Geoff Nash/Simon Hicks | (Corporate Finance) | |
Malar Velaigam | (Corporate Broking) | |
|
| |
Walbrook PR Ltd | Tel: 020 7933 8780 or camcog@walbrookpr.com | |
Lianne Cawthorne | Mob: 07584 391 303 | |
Paul McManus | Mob: 07980 541 893 | |
About Cambridge Cognition
Cambridge Cognition is a world leading provider of computerised cognitive assessment products. The company's range of touch-screen CANTAB™ neuropsychological tests, highly validated over one thousand peer-reviewed publications, are used by both academic scientists in their research, and clinical researchers in the pharmaceutical industry, to maximise knowledge of cognitive function. In addition, the company is committed to broadening the access to this technology and is developing clinical healthcare products under the Cantab mobile brand, to improve the monitoring, management and maintenance of cognitive health and wellbeing. Using these assessments, clinicians can identify and stratify patients so that patient referrals are accurate and efficient, enabling health and social care providers to deliver more effective advice, treatments and care - leading to better outcomes for patients and their families.
Follow the stocks
